Real Science. Real-Time Updates.
The National
Peptide Registry
Navigate the rapidly evolving landscape of peptide therapy with confidence. We are a trusted, unbiased source for clinical data, regulatory news, and patient-driven research.
Unbiased Clinical Data
Cut through the noise. We aggregate and simplify the latest clinical trials, research papers, and peer-reviewed data on peptides so you can make informed decisions based on facts, not hype.
Real-Time Regulatory Alerts
The legal and regulatory status of peptides shifts rapidly. Get immediate updates on FDA actions, compounding pharmacy regulations, and global compliance standards.
Patient-Driven Insights
By joining the registry and securely sharing your experiences, you help researchers, clinicians, and the broader community understand real-world safety, efficacy, and usage trends.
The National Peptide Registry is an informational organization. We do not sell peptides, provide medical advice, or endorse unapproved therapies.
Semaglutide
GLP-1 Receptor Agonist · C₁₈₇H₂₉₁N₄₅O₅₉
Tirzepatide
GIP/GLP-1 Dual Agonist · C₂₂₅H₃₄₈N₄₈O₆₈
BPC-157
Pentadecapeptide · C₆₂H₉₈N₁₆O₂₂
Retatrutide
GIP/GLP-1/Glucagon Triple Agonist
Peptide data,
structured for decisions
Every entry includes standardized classification, molecular data, safety profiles, and real-time regulatory status — all cross-referenced and continuously updated.
- Full molecular formulas and structural identifiers
- Peer-reviewed citations and clinical trial references
- FDA regulatory status and WADA compliance tracking
Your health matters.
Join the movement.
Whether you're a researcher, clinician, or an individual taking your health into your own hands — the National Peptide Registry is your trusted guide.